FDA Approvals - FDA chief: Cuts threaten drug approvals Lorraine McCartin s breast cancer

FDA Approves Novartis' TOBI Podhaler
Novartis AG's TOBI Podhaler (tobramycin inhalation powder) recently received US FDA approval for the treatment of bacterial lung infection in cystic fibrosis patients caused by the Pseudomonas aeruginosa ...

FDA chief: Cuts threaten drug approvals
Lorraine McCartin s breast cancer has been in remission for more than a year, thanks to a drug called Kadcyla that the Food and Drug Administration only recently approved solely for patients with late-stage breast cancer. In 2010, McCartin, 56, of Hanson was able to get access to the drug only by flying to Virginia every three weeks as part of a clinical trial, an expense a friend who also had ...

Biotech Industry Looks to Benefit From FDA 's New "Breakthrough" Designation
Programs developed by the U.S. Food and Drug Administration to speed up the approval process has been a major driver for growth within the Biotech Industry. In 2012, FDA drug approvals totaled a 15-year ...

Notify me with the latest breaking FDA News
	Tell us where to send your notifications:

Read more

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012. The iShares NASDAQ Biotechnology Index , the SPDR S&P Biotech ETF ...

Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech's Industry Success
Programs developed by the U.S. Food and Drug Administration to speed up the approval process has been a major driver for growth within the Biotech Industry. In 2012, FDA drug approvals totaled a 15-year ...

FDA Approves Novartis' TOBI Podhaler
Novartis AG's TOBI Podhaler (tobramycin inhalation powder) recently received US FDA approval for the treatment of bacterial lung infection in cystic fibrosis patients caused by the Pseudomonas aeruginosa ...

Read more